Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenovirus type 5 (Ad5) is a human adenovirus belonging to the family Adenoviridae. It is a medium-sized, non-enveloped virus with an icosahedral capsid structure and a linear, double-stranded DNA genome. Ad5 causes respiratory illnesses ranging from mild pharyngitis or conjunctivitis to severe pneumonia or bronchiolitis. Recombinant vectors based on Ad5 are widely used in gene therapy research but face challenges from pre-existing immunity within human populations.
Cidofovir shows some efficacy against ocular infections caused by adenoviruses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human adenovirus type 5 (Ad5).